Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Clinical Outcomes Among Patients on Apixaban, Rivaroxaban, and Warfarin For AFib and/or VTE"
By
Insights from 2023 ASH Annual Meeting
FEATURING
Jordan Schaefer
By
Insights from 2023 ASH Annual Meeting
FEATURING
Jordan Schaefer
Login to view comments.
Click here to Login